David Schenkein, MD
General Partner·Google Ventures
Cambridge, Massachusetts, United States
David Schenkein is a general partner at GV and co-leads the firm's life science investment team. He invests across therapeutics, diagnostics, medical devices, care delivery, and payer innovation. Before GV, he was CEO and a board member at Agios Pharmaceuticals, held senior oncology roles at Genentech and Millennium Pharmaceuticals, and helped develop Velcade.
See the rest of David Schenkein, MD's profile.
Deal history, investment focus, outreach angles and the rest of the background. One email, no password — we send a link and you land right back here.